Equity Overview
Price & Market Data
Price: $4.28
Daily Change: +$0.22 / 5.14%
Daily Range: $4.04 - $4.36
Market Cap: $8,138,292
Daily Volume: 801
Details
Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, transcriptional regulation, epigenetics, and mitosis control biology in the United States. Its lead product Plogosertib or plogo, a solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia.